 Rachel Friedman
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes | 18 | 2022 | 1996 | 2.830 |
Why?
| | Islets of Langerhans | 7 | 2022 | 803 | 2.070 |
Why?
| | Cell Movement | 9 | 2020 | 971 | 1.290 |
Why?
| | Autoimmunity | 8 | 2021 | 893 | 1.280 |
Why?
| | Antigen-Presenting Cells | 7 | 2021 | 156 | 1.180 |
Why?
| | Diabetes Mellitus, Type 1 | 11 | 2022 | 3697 | 1.130 |
Why?
| | CD11c Antigen | 3 | 2019 | 41 | 0.840 |
Why?
| | CD8-Positive T-Lymphocytes | 7 | 2022 | 916 | 0.800 |
Why?
| | Cell Communication | 5 | 2014 | 313 | 0.790 |
Why?
| | B-Lymphocytes, Regulatory | 1 | 2022 | 3 | 0.760 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2021 | 44 | 0.730 |
Why?
| | Phagocytes | 1 | 2021 | 100 | 0.690 |
Why?
| | Disasters | 1 | 2022 | 98 | 0.690 |
Why?
| | Autoantigens | 4 | 2018 | 429 | 0.650 |
Why?
| | Mice, Inbred NOD | 7 | 2022 | 601 | 0.630 |
Why?
| | Antigen Presentation | 7 | 2017 | 216 | 0.600 |
Why?
| | Stress, Physiological | 2 | 2022 | 444 | 0.590 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2021 | 192 | 0.580 |
Why?
| | Homeostasis | 1 | 2022 | 622 | 0.570 |
Why?
| | Lymphocyte Activation | 11 | 2022 | 1150 | 0.570 |
Why?
| | B-Lymphocytes | 4 | 2019 | 844 | 0.560 |
Why?
| | Dendritic Cells | 6 | 2018 | 488 | 0.550 |
Why?
| | Coronary Artery Disease | 1 | 2022 | 701 | 0.480 |
Why?
| | Immunological Synapses | 2 | 2013 | 16 | 0.450 |
Why?
| | Cellular Microenvironment | 2 | 2014 | 84 | 0.450 |
Why?
| | Signal Transduction | 7 | 2024 | 5077 | 0.440 |
Why?
| | Animals | 33 | 2024 | 36915 | 0.420 |
Why?
| | Lymph Nodes | 5 | 2018 | 493 | 0.420 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1033 | 0.410 |
Why?
| | Peripheral Tolerance | 1 | 2013 | 15 | 0.410 |
Why?
| | Telemedicine | 1 | 2022 | 843 | 0.400 |
Why?
| | Hypertension | 1 | 2022 | 1291 | 0.400 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2014 | 719 | 0.400 |
Why?
| | Cancer Vaccines | 2 | 2004 | 173 | 0.390 |
Why?
| | Mice | 22 | 2024 | 17775 | 0.370 |
Why?
| | Cell Adhesion Molecules | 3 | 2022 | 183 | 0.360 |
Why?
| | Therapeutic Touch | 1 | 2010 | 3 | 0.350 |
Why?
| | CD4-Positive T-Lymphocytes | 6 | 2018 | 1092 | 0.320 |
Why?
| | Microfilament Proteins | 2 | 2022 | 131 | 0.310 |
Why?
| | Antigens | 3 | 2021 | 358 | 0.310 |
Why?
| | Mice, Inbred C57BL | 10 | 2022 | 5766 | 0.300 |
Why?
| | Heart Failure | 1 | 2022 | 2210 | 0.300 |
Why?
| | Asthma | 1 | 2022 | 2285 | 0.290 |
Why?
| | Epitopes, T-Lymphocyte | 3 | 2004 | 187 | 0.290 |
Why?
| | Listeria monocytogenes | 2 | 2017 | 126 | 0.280 |
Why?
| | Phosphoproteins | 2 | 2022 | 338 | 0.280 |
Why?
| | Regeneration | 1 | 2009 | 194 | 0.270 |
Why?
| | Mice, Knockout | 11 | 2020 | 2998 | 0.270 |
Why?
| | Acute Coronary Syndrome | 1 | 2010 | 275 | 0.270 |
Why?
| | Mice, Transgenic | 6 | 2021 | 2182 | 0.260 |
Why?
| | Chromogranin A | 2 | 2018 | 42 | 0.260 |
Why?
| | Wound Healing | 1 | 2009 | 327 | 0.260 |
Why?
| | Heart Rate | 1 | 2010 | 830 | 0.250 |
Why?
| | Intracellular Fluid | 1 | 2005 | 28 | 0.250 |
Why?
| | Extracellular Fluid | 1 | 2005 | 30 | 0.240 |
Why?
| | Chemokines | 1 | 2006 | 229 | 0.240 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 3 | 2013 | 69 | 0.230 |
Why?
| | Stem Cells | 1 | 2009 | 589 | 0.230 |
Why?
| | Immune Tolerance | 2 | 2021 | 362 | 0.230 |
Why?
| | Receptor, EphB4 | 1 | 2024 | 37 | 0.230 |
Why?
| | Ephrin-B2 | 1 | 2024 | 51 | 0.220 |
Why?
| | High Mobility Group Proteins | 1 | 2004 | 44 | 0.220 |
Why?
| | Epitopes | 1 | 2005 | 479 | 0.210 |
Why?
| | Aging | 2 | 2015 | 1863 | 0.210 |
Why?
| | Biomedical Research | 1 | 2009 | 688 | 0.200 |
Why?
| | Nonmuscle Myosin Type IIA | 2 | 2014 | 8 | 0.200 |
Why?
| | Trans-Activators | 2 | 2009 | 399 | 0.200 |
Why?
| | Actins | 2 | 2022 | 416 | 0.190 |
Why?
| | Cell Adhesion | 4 | 2017 | 466 | 0.190 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.180 |
Why?
| | HIV Antigens | 1 | 2000 | 17 | 0.180 |
Why?
| | Recombination, Genetic | 2 | 2018 | 198 | 0.170 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 176 | 0.170 |
Why?
| | Conservation of Natural Resources | 1 | 2021 | 122 | 0.170 |
Why?
| | Airway Remodeling | 1 | 2020 | 64 | 0.160 |
Why?
| | Humans | 21 | 2024 | 136899 | 0.160 |
Why?
| | Immune System | 2 | 2013 | 177 | 0.160 |
Why?
| | Adenine | 1 | 2021 | 267 | 0.160 |
Why?
| | Wnt Proteins | 1 | 2020 | 133 | 0.160 |
Why?
| | Piperazines | 1 | 2021 | 349 | 0.150 |
Why?
| | Head and Neck Neoplasms | 1 | 2024 | 617 | 0.150 |
Why?
| | Neovascularization, Pathologic | 1 | 2020 | 300 | 0.150 |
Why?
| | Myeloid Cells | 1 | 2019 | 146 | 0.150 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 193 | 0.150 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2018 | 46 | 0.140 |
Why?
| | Endothelial Cells | 3 | 2020 | 779 | 0.140 |
Why?
| | Ambulatory Care | 1 | 2022 | 528 | 0.140 |
Why?
| | Molecular Imaging | 1 | 2018 | 55 | 0.140 |
Why?
| | Membrane Proteins | 1 | 2004 | 1167 | 0.140 |
Why?
| | C-Peptide | 1 | 2018 | 161 | 0.140 |
Why?
| | Receptors, Interferon | 1 | 2017 | 51 | 0.130 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2018 | 137 | 0.130 |
Why?
| | Cells, Cultured | 4 | 2018 | 4204 | 0.130 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2017 | 31 | 0.130 |
Why?
| | Hospitals | 1 | 2022 | 678 | 0.130 |
Why?
| | Interleukin-4 | 1 | 2018 | 217 | 0.130 |
Why?
| | Listeriosis | 1 | 2017 | 70 | 0.130 |
Why?
| | Ecosystem | 1 | 2021 | 591 | 0.130 |
Why?
| | Prostatic Neoplasms | 1 | 2004 | 1033 | 0.130 |
Why?
| | Spleen | 2 | 2015 | 516 | 0.120 |
Why?
| | Disease Progression | 2 | 2019 | 2744 | 0.110 |
Why?
| | Flow Cytometry | 4 | 2015 | 1185 | 0.110 |
Why?
| | HIV-1 | 1 | 2000 | 862 | 0.110 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 922 | 0.110 |
Why?
| | Peptide Fragments | 3 | 2018 | 707 | 0.100 |
Why?
| | Phenotype | 1 | 2022 | 3201 | 0.100 |
Why?
| | Alum Compounds | 1 | 2013 | 22 | 0.100 |
Why?
| | Female | 12 | 2021 | 72703 | 0.100 |
Why?
| | Inflammation | 3 | 2020 | 2817 | 0.100 |
Why?
| | Gene Expression | 1 | 2018 | 1505 | 0.100 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2013 | 68 | 0.100 |
Why?
| | Chemokine CCL21 | 2 | 2015 | 14 | 0.100 |
Why?
| | Receptors, CCR7 | 2 | 2015 | 32 | 0.100 |
Why?
| | Cell Line, Tumor | 3 | 2024 | 3396 | 0.100 |
Why?
| | Internship and Residency | 1 | 2022 | 1131 | 0.090 |
Why?
| | Adjuvants, Immunologic | 1 | 2013 | 226 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 368 | 0.090 |
Why?
| | Immunity, Cellular | 1 | 2013 | 267 | 0.090 |
Why?
| | Interferon-gamma | 1 | 2014 | 790 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2004 | 2490 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2033 | 0.090 |
Why?
| | Music Therapy | 1 | 2010 | 23 | 0.080 |
Why?
| | Autoimmune Diseases | 2 | 2018 | 459 | 0.080 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 2 | 2008 | 31 | 0.080 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2010 | 63 | 0.080 |
Why?
| | Fluorescence | 1 | 2010 | 161 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2143 | 0.080 |
Why?
| | Cell Transplantation | 1 | 2009 | 37 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2004 | 2901 | 0.080 |
Why?
| | Macrophages | 1 | 2017 | 1547 | 0.080 |
Why?
| | Self Tolerance | 1 | 2008 | 28 | 0.070 |
Why?
| | Obesity | 1 | 2022 | 2966 | 0.070 |
Why?
| | Hepatocytes | 1 | 2009 | 220 | 0.070 |
Why?
| | Lymphoid Tissue | 1 | 2008 | 75 | 0.070 |
Why?
| | Stem Cell Transplantation | 1 | 2009 | 177 | 0.070 |
Why?
| | Paracrine Communication | 1 | 2008 | 64 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 286 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2508 | 0.070 |
Why?
| | Lung | 1 | 2020 | 4046 | 0.070 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 145 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2008 | 455 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2006 | 47 | 0.070 |
Why?
| | Chemokines, CC | 1 | 2006 | 33 | 0.070 |
Why?
| | Cell Differentiation | 2 | 2018 | 1976 | 0.060 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2006 | 139 | 0.060 |
Why?
| | Mice, Mutant Strains | 1 | 2006 | 300 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1460 | 0.060 |
Why?
| | Mice, Inbred Strains | 1 | 2006 | 413 | 0.060 |
Why?
| | Emotions | 1 | 2010 | 585 | 0.060 |
Why?
| | Mice, Inbred BALB C | 3 | 2015 | 1271 | 0.060 |
Why?
| | Cell Line | 2 | 2020 | 2847 | 0.060 |
Why?
| | SOXC Transcription Factors | 1 | 2004 | 5 | 0.060 |
Why?
| | Ligands | 1 | 2006 | 665 | 0.060 |
Why?
| | Antibodies, Neoplasm | 1 | 2004 | 35 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 2 | 2004 | 557 | 0.050 |
Why?
| | COS Cells | 1 | 2004 | 188 | 0.050 |
Why?
| | Antibody Specificity | 1 | 2004 | 189 | 0.050 |
Why?
| | Antigens, CD | 1 | 2006 | 524 | 0.050 |
Why?
| | Carcinoma, Small Cell | 1 | 2004 | 172 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2004 | 184 | 0.050 |
Why?
| | Recombinant Proteins | 3 | 2002 | 1357 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 212 | 0.050 |
Why?
| | Kallikreins | 1 | 2002 | 29 | 0.050 |
Why?
| | Clone Cells | 2 | 2018 | 266 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 658 | 0.050 |
Why?
| | Accreditation | 1 | 2022 | 84 | 0.050 |
Why?
| | Adoptive Transfer | 2 | 2015 | 224 | 0.050 |
Why?
| | Male | 8 | 2020 | 67308 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 156 | 0.050 |
Why?
| | Transfection | 1 | 2004 | 948 | 0.050 |
Why?
| | Polymerization | 1 | 2022 | 126 | 0.050 |
Why?
| | Prostate-Specific Antigen | 1 | 2002 | 161 | 0.050 |
Why?
| | Listeria | 1 | 2000 | 5 | 0.040 |
Why?
| | Gene Products, nef | 1 | 2000 | 12 | 0.040 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 19 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2004 | 1061 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 432 | 0.040 |
Why?
| | Gene Products, gag | 1 | 2000 | 36 | 0.040 |
Why?
| | Hospitalization | 1 | 2010 | 2183 | 0.040 |
Why?
| | Lymphatic System | 1 | 2020 | 13 | 0.040 |
Why?
| | AIDS Vaccines | 1 | 2000 | 52 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 682 | 0.040 |
Why?
| | Transcription Factors | 1 | 2008 | 1715 | 0.040 |
Why?
| | Alanine | 1 | 2000 | 153 | 0.040 |
Why?
| | Vascular System Injuries | 1 | 2020 | 73 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2000 | 322 | 0.040 |
Why?
| | Faculty, Medical | 1 | 2022 | 283 | 0.040 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2018 | 60 | 0.040 |
Why?
| | Crosses, Genetic | 1 | 2018 | 137 | 0.040 |
Why?
| | beta Catenin | 1 | 2020 | 251 | 0.040 |
Why?
| | Sex Factors | 1 | 2004 | 2067 | 0.040 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1998 | 225 | 0.040 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 42 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2017 | 88 | 0.040 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 1998 | 173 | 0.040 |
Why?
| | Monocytes | 1 | 2000 | 567 | 0.030 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 476 | 0.030 |
Why?
| | Germinal Center | 1 | 2018 | 58 | 0.030 |
Why?
| | Heat-Shock Proteins | 1 | 1998 | 142 | 0.030 |
Why?
| | Mice, SCID | 1 | 2018 | 367 | 0.030 |
Why?
| | Integrin alpha4 | 1 | 2017 | 7 | 0.030 |
Why?
| | Pulmonary Emphysema | 1 | 2020 | 284 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2018 | 268 | 0.030 |
Why?
| | Chemotaxis | 1 | 2017 | 131 | 0.030 |
Why?
| | Microscopy | 1 | 2018 | 144 | 0.030 |
Why?
| | Interferon Type I | 1 | 2017 | 142 | 0.030 |
Why?
| | Macrophage Activation | 1 | 2017 | 201 | 0.030 |
Why?
| | Chemokine CCL19 | 1 | 2015 | 6 | 0.030 |
Why?
| | Curriculum | 1 | 2022 | 978 | 0.030 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 1079 | 0.030 |
Why?
| | Microsatellite Repeats | 1 | 2015 | 168 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 658 | 0.030 |
Why?
| | Middle Aged | 2 | 2020 | 33118 | 0.030 |
Why?
| | Clinical Competence | 1 | 2022 | 1086 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2017 | 424 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 784 | 0.030 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2615 | 0.020 |
Why?
| | Software | 1 | 2018 | 670 | 0.020 |
Why?
| | Cytokinesis | 1 | 2013 | 48 | 0.020 |
Why?
| | Mice, Nude | 1 | 2013 | 696 | 0.020 |
Why?
| | Cell Fractionation | 2 | 2002 | 56 | 0.020 |
Why?
| | Lymphopenia | 1 | 2010 | 61 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1762 | 0.020 |
Why?
| | Immune System Phenomena | 1 | 2009 | 2 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2008 | 33 | 0.020 |
Why?
| | Tumor Cells, Cultured | 2 | 2002 | 950 | 0.020 |
Why?
| | STAT5 Transcription Factor | 1 | 2008 | 57 | 0.020 |
Why?
| | Stromal Cells | 1 | 2008 | 111 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2009 | 318 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 394 | 0.020 |
Why?
| | Autoantibodies | 1 | 2015 | 1498 | 0.020 |
Why?
| | Thymus Gland | 1 | 2008 | 312 | 0.020 |
Why?
| | Biomarkers | 1 | 2018 | 4148 | 0.020 |
Why?
| | HIV Infections | 1 | 2000 | 2822 | 0.020 |
Why?
| | Homeodomain Proteins | 1 | 2009 | 504 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13157 | 0.010 |
Why?
| | HLA-D Antigens | 1 | 2002 | 34 | 0.010 |
Why?
| | Hybridomas | 1 | 2002 | 237 | 0.010 |
Why?
| | Proteins | 1 | 2008 | 1012 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2008 | 1097 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1458 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2002 | 239 | 0.010 |
Why?
| | Multigene Family | 1 | 2002 | 202 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2008 | 2471 | 0.010 |
Why?
| | Aged | 1 | 2020 | 23641 | 0.010 |
Why?
| | Leukemia, Erythroblastic, Acute | 1 | 1998 | 7 | 0.010 |
Why?
| | Chemical Precipitation | 1 | 1998 | 38 | 0.010 |
Why?
| | Granzymes | 1 | 1998 | 49 | 0.010 |
Why?
| | Serine Endopeptidases | 1 | 1998 | 123 | 0.010 |
Why?
| | Cytoplasm | 1 | 1998 | 274 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1998 | 385 | 0.010 |
Why?
| | Adult | 1 | 2020 | 37595 | 0.010 |
Why?
| | Cell Death | 1 | 1998 | 370 | 0.010 |
Why?
| | Enzyme Activation | 1 | 1998 | 816 | 0.010 |
Why?
| | Immunity, Innate | 1 | 2002 | 832 | 0.010 |
Why?
| | Hot Temperature | 1 | 1998 | 407 | 0.010 |
Why?
| | Protein Binding | 1 | 1998 | 2222 | 0.010 |
Why?
| | Time Factors | 1 | 1998 | 6802 | 0.000 |
Why?
|
|
Friedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|